Engineering Bacteria and Their Derivatives for Cancer Immunotherapy
Leveraging bacteria for cancer immunotherapy has gradually attracted wide attention since the discovery of “Cloey’s toxin.” However, one of the persistent challenges for bacteria-based therapy is striking a balance between safety and immunogenicity. Genetically engineered bacteria with virulence fac...
Furkejuvvon:
| Váldodahkkit: | , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
American Association for the Advancement of Science (AAAS)
2024-01-01
|
| Ráidu: | BME Frontiers |
| Liŋkkat: | https://spj.science.org/doi/10.34133/bmef.0047 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|